Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults-Reference-Cited by-同舟云学术

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults

Published:2023-07-12 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Costa Clemens Sue Ann¹²,Marchevsky Natalie¹³,Kelly Sarah¹³,Felle Sally¹³,Eldawi Ahmed¹³,Rajasingam Rupetha¹³,Mahmud Rawan¹³,Lambe Teresa¹⁴,Voysey Merryn¹³,Gonzalez Isabela²,Milan Eveline Pipolo⁵,Justino Maria Cleonice⁶,Bibi Sagida¹³,Aley Parvinder¹³,Clemens Ralf⁷,Pollard Andrew J.¹³

Affiliation:

1. Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, UK

2. Institute for Global Health, University of Siena, Siena, Italy

3. NIHR Oxford Biomedical Research Centre, Oxford, UK

4. Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK

5. Centro de Estudos e Pesquisa em Moléstias Infecciosas Ltda. (CEPCLIN), Natal, Brazil

6. Instituto Evandro Chagas, Health Surveillance Secretariat, Brazilian Ministry of Health, Ananindeua, Pará, Brazil

7. GRID RIO, Rio de Janeiro, Brazil

Funder

Coalition for Epidemic Preparedness Innovations

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2233400

Reference30 articles.

1. New variant of SARS-CoV-2 in UK causes surge of COVID-19

2. Covid-19: Omicron drives weekly record high in global infections

3. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

4. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

5. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster;Vaccines;2024-07-18